| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10967854 | Vaccine | 2012 | 8 Pages |
Abstract
⺠A vaccine formulation containing influenza NP and the PapMV VLPs provide protection to influenza infection. ⺠The increased affinity of PapMV VLPs for NP improves significantly the IgG2a titres to the NP. ⺠The increased affinity of the PapMV VLPs for NP improves significantly the IFN-γ secretion by T cells.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
![Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP]](/preview/png/10967854.png "First Page Preview: Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP]")
Authors
Christian Savard, Marie-Ãve Laliberté-Gagné, Cindy Babin, Marilène Bolduc, Annie Guérin, Karine Drouin, Marie-Andrée Forget, Nathalie Majeau, Réjean Lapointe, Denis Leclerc,